Crystal structure of HLA-A*1101 with sars nucleocapsid peptide

High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide.

HLA class I histocompatibility antigen, A-11 alpha chain

HLA-A*1101 ALPHA-CHAIN, MHC class I antigen A*11

GSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGT
LRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQQRAYL
EGRCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT
FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWE

IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAC
RVNHVTLSQPKIVKWDRDM

25% PEG 5000 MME, 0.2M AMMONIUM SULFATE, 0.1M MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K

CHEMICALLY SYNTHESIZED PEPTIDE. THIS SEQUENCE OCCURS NATURALLY IN SARS CORONAVIRUS NUCLEOCAPSID PROTEIN, POSITION 362-370.

ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY 2.29 %

PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, SARS, IMMUNE SYSTEM